Oral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts

• Main Authors: Kiran Godse (Author), Rashmi Sarkar (Author), Venkataram Mysore (Author), Manunath M Shenoy (Author), Manas Chatterjee (Author), Rajetha Damisetty (Author), Swapnil Shah (Author), Maya Vedamurthy (Author), Sanjeev Aurangabadkar (Author), Chakravarthi Srinivas (Author), Anil Ganjoo (Author), Sudip Das (Author), Anant Patil (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Melasma, a chronic pigmentary skin condition mainly affecting the face, remains a challenge despite the availability of several options for treatment. Many melasma patients are not satisfied with treatment outcomes. Tranexamic acid (TXA), an anti-fibrinolytic drug has shown promising results in pati...